IDT Australia Ltd
ASX:IDT

Watchlist Manager
IDT Australia Ltd Logo
IDT Australia Ltd
ASX:IDT
Watchlist
Price: 0.054 AUD 5.88%
Market Cap: 23.1m AUD

IDT Australia Ltd
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

IDT Australia Ltd
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
IDT Australia Ltd
ASX:IDT
EPS (Diluted)
AU$0
CAGR 3-Years
N/A
CAGR 5-Years
-15%
CAGR 10-Years
0%
Mayne Pharma Group Ltd
ASX:MYX
EPS (Diluted)
-AU$1
CAGR 3-Years
30%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
EPS (Diluted)
AU$1
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Botanix Pharmaceuticals Ltd
ASX:BOT
EPS (Diluted)
AU$0
CAGR 3-Years
-71%
CAGR 5-Years
-20%
CAGR 10-Years
-17%
C
Clarity Pharmaceuticals Ltd
ASX:CU6
EPS (Diluted)
AU$0
CAGR 3-Years
-26%
CAGR 5-Years
-46%
CAGR 10-Years
N/A
Nyrada Inc
ASX:NYR
EPS (Diluted)
AU$0
CAGR 3-Years
13%
CAGR 5-Years
17%
CAGR 10-Years
N/A
No Stocks Found

IDT Australia Ltd
Glance View

Market Cap
23.2m AUD
Industry
Pharmaceuticals

IDT Australia Ltd. produces, develops and supplies pharmaceutical products. The company is headquartered in Melbourne, Victoria. The firm is engaged in the supply of products and provision of research and development and other technical services within the pharmaceutical and allied industries. The firm specializes in the manufacture of Active Pharmaceutical Ingredients (API) and Finished Dose Forms (FDF), microbiological and analytical testing, clinical packaging and pharmacy services. The company provides services for new drug development and scale-up, commercial active drug manufacture as well as a various oral and injectable finished drug dose forms. Its sterile manufacturing suite is designed to liquid fill and lyophilise a range of sterile pharmaceutical and biopharmaceutical drug products. Its current goods manufacturing practices (cGMP) facilities manufactures a range of medicinal cannabis products for local and international markets.

IDT Intrinsic Value
0.154 AUD
Undervaluation 65%
Intrinsic Value
Price

See Also

What is IDT Australia Ltd's EPS (Diluted)?
EPS (Diluted)
-0 AUD

Based on the financial report for Jun 30, 2025, IDT Australia Ltd's EPS (Diluted) amounts to -0 AUD.

What is IDT Australia Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
0%

Over the last year, the EPS (Diluted) growth was 0%.

Back to Top